Ian Ford
#102,808
Most Influential Person Now
Researcher
Ian Ford's AcademicInfluence.com Rankings
Ian Fordcomputer-science Degrees
Computer Science
#3684
World Rank
#3873
Historical Rank
Machine Learning
#508
World Rank
#514
Historical Rank
Artificial Intelligence
#716
World Rank
#727
Historical Rank
Database
#990
World Rank
#1042
Historical Rank
Download Badge
Computer Science
Ian Ford's Degrees
- PhD Computer Science Stanford University
- Masters Artificial Intelligence University of California, Berkeley
Similar Degrees You Can Earn
Why Is Ian Ford Influential?
(Suggest an Edit or Addition)Ian Ford's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia (1995) (5842)
- Genetic studies of body mass index yield new insights for obesity biology (2015) (3549)
- Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial (2002) (3200)
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. (1995) (2355)
- Defining the role of common variation in the genomic and biological architecture of adult human height (2014) (1805)
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study (2010) (1777)
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials (2010) (1770)
- Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. (2015) (1708)
- Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study (2003) (1584)
- A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease (2015) (1567)
- Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. (2005) (1195)
- Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture (2012) (1045)
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial (2017) (1038)
- Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps (2018) (1028)
- Biochemical detection of left-ventricular systolic dysfunction (1998) (1027)
- Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial (2008) (1000)
- 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). (2014) (983)
- C-reactive protein, fibrinogen, and cardiovascular disease prediction. (2012) (952)
- Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study (2001) (896)
- 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). (2014) (880)
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis (2012) (864)
- Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial (2004) (802)
- Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial (2015) (787)
- Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial (2008) (774)
- Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. (2000) (771)
- Pragmatic Trials. (2016) (765)
- Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways (2012) (758)
- MRI‐Guided Thrombolysis for Stroke with Unknown Time of Onset (2018) (757)
- A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance (2012) (756)
- C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. (2002) (754)
- Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population (1997) (663)
- Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry (2012) (619)
- Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial (2002) (616)
- Randomised controlled trial of specialist nurse intervention in heart failure (2001) (586)
- Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study (2007) (579)
- Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. (2005) (568)
- HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (2015) (559)
- Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data (2014) (547)
- The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study (2015) (532)
- Rare and low-frequency coding variants alter human adult height (2016) (511)
- Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies (2008) (499)
- The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. (1999) (482)
- Effects of exogenous melatonin on sleep: a meta-analysis. (2005) (473)
- Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. (2010) (457)
- Lipid-related markers and cardiovascular disease prediction. (2012) (457)
- Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. (2013) (438)
- Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease (2016) (434)
- Exome-wide association study of plasma lipids in >300,000 individuals (2017) (428)
- Multi-ethnic genome-wide association study for atrial fibrillation (2018) (425)
- World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions (2019) (423)
- Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function (2018) (417)
- The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. (2004) (413)
- Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial (2004) (407)
- Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. (2019) (403)
- Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure (2011) (399)
- Ivabradine in stable coronary artery disease without clinical heart failure. (2014) (395)
- Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (2016) (388)
- Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial (2010) (381)
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
- Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. (2004) (376)
- Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. (2013) (343)
- Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis (2018) (340)
- Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting (2017) (338)
- Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study (2016) (332)
- Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949) (2015) (328)
- Electronic health records to facilitate clinical research (2016) (322)
- Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. (2016) (309)
- Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure (2020) (288)
- Outcomes of elective induction of labour compared with expectant management: population based study (2012) (286)
- Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. (1985) (283)
- PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study (2017) (283)
- Long-term follow-up of the West of Scotland Coronary Prevention Study. (2007) (280)
- Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population (2001) (278)
- Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy (2011) (275)
- The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. (2014) (268)
- Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. (2005) (265)
- Pravastatin and cognitive function in the elderly. Results of the PROSPER study (2009) (255)
- Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial (2016) (253)
- ESC / ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management (2014) (249)
- Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study. (2012) (246)
- Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study (2001) (245)
- Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation (2017) (243)
- Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability (2006) (240)
- Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI randomized trial (2014) (240)
- Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age (2014) (238)
- Novel genetic loci associated with hippocampal volume (2017) (238)
- Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension (2016) (234)
- Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data (2019) (231)
- Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. (1996) (226)
- Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study (2012) (221)
- Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. (2018) (221)
- Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. (2012) (220)
- Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data (2018) (217)
- Blood Rheology, Cardiovascular Risk Factors, and Cardiovascular Disease: The West of Scotland Coronary Prevention Study (2000) (215)
- Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. (2017) (214)
- Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. (2009) (213)
- A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI) (2014) (210)
- Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes (2007) (209)
- The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin (1997) (209)
- Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins (2014) (207)
- Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease (2009) (207)
- Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease (2017) (204)
- Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study (2015) (202)
- SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. (2021) (200)
- Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial (2011) (197)
- Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study. (2011) (196)
- A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function (2013) (193)
- Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure underpinning obesity (2017) (193)
- Novel genetic loci underlying human intracranial volume identified through genome-wide association (2016) (192)
- Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome (2012) (191)
- Glycated hemoglobin measurement and prediction of cardiovascular disease. (2014) (189)
- Mortality in heart failure: clinical variables of prognostic value. (1987) (184)
- Socio-economic status is associated with epigenetic differences in the pSoBid cohort. (2012) (181)
- Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism (2017) (180)
- Genome-Wide Association and Functional Follow-Up Reveals New Loci for Kidney Function (2012) (180)
- High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants (2017) (180)
- Presentation, management, and outcome of out of hospital cardiopulmonary arrest: comparison by underlying aetiology (2003) (178)
- Integrating Genetic, Transcriptional, and Functional Analyses to Identify 5 Novel Genes for Atrial Fibrillation (2014) (177)
- High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease (2016) (177)
- Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. (2012) (174)
- Intravenous Iron in Patients Undergoing Maintenance Hemodialysis (2019) (167)
- Association of Thyroid Hormone Therapy With Quality of Life and Thyroid-Related Symptoms in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis (2018) (165)
- The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. (1996) (160)
- Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris (2012) (155)
- The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases (2007) (155)
- Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. (2013) (154)
- Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies (2018) (153)
- Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. (2014) (153)
- Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. (1987) (152)
- Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis (2014) (149)
- Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits (2017) (149)
- Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels (2016) (147)
- Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation (2011) (145)
- Stepping down inhaled corticosteroids in asthma: randomised controlled trial (2003) (144)
- Directional dominance on stature and cognition in diverse human populations (2015) (144)
- Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study (2012) (143)
- Myocardial Hemorrhage After Acute Reperfused ST-Segment–Elevation Myocardial Infarction (2016) (141)
- Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. (2012) (140)
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety (2010) (140)
- Testing cognitive function in elderly populations: the PROSPER study (2002) (139)
- Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis. (2015) (139)
- Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial (2013) (138)
- Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. (2014) (137)
- Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease (2004) (136)
- Association Between Apolipoprotein E4 and Cognitive Decline in Elderly Adults (2007) (136)
- Local or General Anesthesia for Open Hernia Repair: A Randomized Trial (2003) (131)
- C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) (2007) (130)
- Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study (2013) (130)
- Effect of socioeconomic deprivation on waiting time for cardiac surgery: retrospective cohort study. (2000) (129)
- Severe hypotension after first dose of enalapril in heart failure. (1985) (128)
- Accelerated Telomere Attrition Is Associated with Relative Household Income, Diet and Inflammation in the pSoBid Cohort (2011) (127)
- GWAS for executive function and processing speed suggests involvement of the CADM2 gene (2016) (125)
- Survival of 1476 patients initially resuscitated from out of hospital cardiac arrest (1996) (123)
- The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials (2015) (123)
- Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) (2005) (122)
- Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. (2014) (121)
- Pathophysiology of LV Remodeling in Survivors of STEMI (2015) (120)
- Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach. (2009) (120)
- Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention Study (2007) (120)
- Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies (2016) (118)
- Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. (2013) (118)
- Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. (1998) (118)
- Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity (2017) (117)
- Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation (2018) (117)
- Comparative Prognostic Utility of Indexes of Microvascular Function Alone or in Combination in Patients With an Acute ST-Segment–Elevation Myocardial Infarction (2016) (115)
- Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors (2015) (112)
- Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial (2020) (110)
- Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. (2011) (110)
- Are Markers of Inflammation More Strongly Associated with Risk for Fatal Than for Nonfatal Vascular Events? (2009) (109)
- Potential impact of public access defibrillators on survival after out of hospital cardiopulmonary arrest: retrospective cohort study (2002) (107)
- Intravenous Iron in Patients Undergoing Maintenance Hemodialysis. (2019) (107)
- Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms (2010) (104)
- Temporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST‐Segment Elevation Myocardial Infarction: Pathophysiological Insights and Clinical Implications (2016) (103)
- Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study (2011) (102)
- Circulating interleukin‐6 concentration and cognitive decline in old age: the PROSPER study (2013) (100)
- Heart rate reduction in cardiovascular disease and therapy (2010) (99)
- 52 Genetic Loci Influencing Myocardial Mass. (2016) (98)
- The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study (2010) (98)
- Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice (1997) (98)
- Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials. (2013) (96)
- Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study. (2013) (96)
- Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response (2011) (95)
- Rationale and design of a randomized, double‐blind, placebo‐controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT) (2010) (93)
- Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. (1991) (93)
- Cognitive behaviour therapy for violent men with antisocial personality disorder in the community: an exploratory randomized controlled trial (2008) (93)
- Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta‐analysis (2018) (92)
- Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease (2012) (92)
- A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease (2016) (92)
- Effect of pravastatin on cerebral infarcts and white matter lesions (2005) (92)
- Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study (2013) (91)
- Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy 20-Year Follow-Up of West of Scotland Coronary Prevention Study (2016) (90)
- Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. (2002) (89)
- Microvascular Resistance Predicts Myocardial Salvage and Infarct Characteristics in ST‐Elevation Myocardial Infarction (2012) (88)
- Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation (2020) (88)
- Leptin Predicts Diabetes but Not Cardiovascular Disease (2009) (88)
- The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial (2016) (87)
- Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL. (2011) (86)
- Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium. (2015) (85)
- 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) (2014) (83)
- Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review. (2014) (82)
- Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. (2013) (80)
- Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial (2016) (80)
- Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia (2014) (80)
- Secretory Phospholipase A2-IIA and Cardiovascular Disease (2013) (78)
- Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data (2020) (78)
- Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. (2008) (78)
- Genetic Risk Prediction of Atrial Fibrillation (2017) (77)
- Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER. (2008) (76)
- Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial (2019) (75)
- Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and (2017) (74)
- Circulating Interleukin-10 and Risk of Cardiovascular Events: A Prospective Study in the Elderly at Risk (2011) (74)
- Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium (2013) (73)
- Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT) (2016) (73)
- Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial (2017) (73)
- Early treatment with captopril after acute myocardial infarction. (1993) (73)
- KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study (2010) (72)
- Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) (2012) (71)
- Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency (2016) (71)
- Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study (2013) (70)
- The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial. (2015) (68)
- Genome-wide association study of genetic determinants of LDL- c response to atorvastatin therapy: importance of Lp(a) (2012) (68)
- Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism. (2019) (67)
- Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. (2012) (67)
- Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer. (1990) (66)
- Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. (2013) (66)
- Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based study (2009) (66)
- A saturated map of common genetic variants associated with human height (2022) (65)
- Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics (2014) (65)
- Long Term Safety and Efficacy of Lowering LDL Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study (2016) (65)
- Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study (2016) (64)
- Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure. (1984) (63)
- Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) Study (2017) (63)
- Genetic Predictors of Fibrin D-Dimer Levels in Healthy Adults (2011) (63)
- Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial (2015) (62)
- Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy (2016) (61)
- The incidence and risk factors for new onset atrial fibrillation in the PROSPER study. (2011) (61)
- Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT‐HF) ☆ (2008) (61)
- Symptom Onset in Aortic Stenosis: Relation to Sex Differences in Left Ventricular Remodeling. (2017) (61)
- Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS). (2002) (60)
- Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers (2015) (60)
- Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients (2014) (60)
- The role of covariates in estimating treatment effects and risk in long‐term clinical trials (2002) (59)
- Adipocytokines and risk of stroke in older people: a nested case-control study. (2009) (59)
- Reduced Glomerular Filtration Rate and Its Association with Clinical Outcome in Older Patients at Risk of Vascular Events: Secondary Analysis (2009) (59)
- Lipoprotein-associated phospholipase A(2) as an independent predictor of coronary heart disease (2000) (59)
- Soluble ST2 Associates with Diabetes but Not Established Cardiovascular Risk Factors: A New Inflammatory Pathway of Relevance to Diabetes? (2012) (59)
- Stenting for symptomatic vertebral artery stenosis (2017) (59)
- Twenty‐four‐hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy (2015) (58)
- Red cell distribution width has incremental prognostic value to B‐type natriuretic peptide in acute heart failure (2009) (58)
- Apolipoprotein e genotype, plasma cholesterol, and cancer: a Mendelian randomization study. (2009) (58)
- Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People? (2008) (58)
- Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis. (2016) (58)
- Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability (2020) (58)
- Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study (2013) (58)
- Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial). (2015) (57)
- Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease (2004) (57)
- PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population[S] (2013) (57)
- Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population. (2008) (57)
- The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population (2007) (56)
- High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort (2016) (56)
- Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial. (2019) (56)
- Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT (2014) (56)
- Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry (2015) (56)
- International economic analysis of primary prevention of cardiovascular disease with pravastatin in WOSCOPS. West of Scotland Coronary Prevention Study. (1999) (56)
- Socioeconomic status and telomere length: the West of Scotland Coronary Prevention Study (2009) (56)
- The changing course of aortic valve disease in Scotland: temporal trends in hospitalizations and mortality and prognostic importance of aortic stenosis. (2013) (55)
- Fine-mapping of an expanded set of type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps (2018) (55)
- Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019) (55)
- Systematically missing confounders in individual participant data meta-analysis of observational cohort studies (2009) (54)
- Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect? (2009) (54)
- Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a) [S] (2012) (54)
- Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses (2011) (53)
- The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. (2011) (53)
- Tenecteplase in ischemic stroke offers improved recanalization (2017) (53)
- Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study (2016) (53)
- Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium (2015) (53)
- Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2020) (53)
- Stratification by Smoking Status Reveals an Association of CHRNA5-A3-B4 Genotype with Body Mass Index in Never Smokers (2014) (52)
- Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies (2013) (52)
- N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS (2012) (52)
- Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly[S] (2010) (51)
- LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-Cholesterol Levels of 190 mg/dL or Above: Analyses from the WOSCOPS 5-year Randomised Trial and 20-year Observational Follow-Up (2017) (50)
- Patients’ Perspectives on Statin Therapy for Treatment of Hypercholesterolaemia: A Qualitative Study (2003) (50)
- The value of routine non-invasive tests to predict clinical outcome in stable angina. (2003) (50)
- Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) (2013) (48)
- Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial. (2016) (48)
- Predictors of functional decline in elderly people with vascular risk factors or disease. (2005) (48)
- Low-Density Lipoprotein Cholesterol Determines Oxidative Stress and Endothelial Dysfunction in Saphenous Veins From Patients With Coronary Artery Disease (2006) (47)
- β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study (2019) (47)
- Persistent Iron Within the Infarct Core After ST-Segment Elevation Myocardial Infarction (2017) (46)
- Risk following hospitalization in stable chronic systolic heart failure (2013) (46)
- Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry (2019) (46)
- Genome-wide Trans-ethnic Meta-analysis Identifies Seven Genetic Loci Influencing Erythrocyte Traits and a Role for RBPMS in Erythropoiesis. (2017) (46)
- Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort (2017) (46)
- Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial (2010) (46)
- Genetic Variation in the Interleukin‐10 Gene Promoter and Risk of Coronary and Cerebrovascular Events (2007) (45)
- Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke A Randomized, Doubleblind, Placebo-Controlled Trial) (2017) (45)
- Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study). (2014) (45)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2019) (45)
- Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial (2021) (45)
- Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. (2013) (45)
- Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use (2019) (45)
- Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. (2015) (44)
- Measures to assess the prognostic ability of the stratified Cox proportional hazards model (2009) (44)
- Are Routinely Collected NHS Administrative Records Suitable for Endpoint Identification in Clinical Trials? Evidence from the West of Scotland Coronary Prevention Study (2013) (44)
- Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial. (2020) (44)
- Remote Zone Extracellular Volume and Left Ventricular Remodeling in Survivors of ST-Elevation Myocardial Infarction (2016) (44)
- Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial (2018) (44)
- Activation of Hemostasis and Decline in Cognitive Function in Older People (2010) (43)
- Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk Model. (2015) (43)
- Socioeconomic Deprivation and Cortical Morphology: Psychological, Social, and Biological Determinants of Ill Health Study (2013) (43)
- Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction (2016) (42)
- A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics (2002) (42)
- Nuclear magnetic resonance‐based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997 (2017) (42)
- Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension (2018) (42)
- Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction (2019) (42)
- Up-titration of allopurinol in patients with gout. (2014) (41)
- The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT (2013) (41)
- Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease. (2017) (40)
- Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST) (2017) (40)
- Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment (2018) (40)
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. (2021) (40)
- Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease (2017) (40)
- A panel study of air pollution in subjects with heart failure: negative results in treated patients (2008) (40)
- Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2 (2014) (39)
- Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT (2018) (38)
- Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post‐hoc analysis of SHIFT (2016) (38)
- Risk for Incident Heart Failure: A Subject‐Level Meta‐Analysis From the Heart “OMics” in AGEing (HOMAGE) Study (2017) (38)
- Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction (2019) (38)
- Leveraging electronic health records for clinical research (2018) (37)
- Psychological, social and biological determinants of ill health (pSoBid): Study Protocol of a population-based study (2008) (37)
- Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure. (2007) (37)
- Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study (2016) (37)
- Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. (2010) (36)
- [2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement]. (2014) (36)
- Subclinical thyroid dysfunction and functional capacity among elderly. (2014) (36)
- Biogerontology: Mechanisms and Interventions (2007) (35)
- Common variants in Mendelian kidney disease genes and their association with renal function. (2013) (35)
- Meta-analysis of 49 549 individuals imputed with the 1000 Genomes Project reveals an exonic damaging variant in ANGPTL4 determining fasting TG levels (2016) (34)
- Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. (2016) (34)
- A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus (2013) (34)
- The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study: Baseline Characteristics of the Population (2009) (34)
- Personality, Socio-Economic Status and Inflammation: Cross-Sectional, Population-Based Study (2013) (34)
- Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data (2018) (34)
- Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy). (2011) (34)
- Associations Between Thrombin Generation and the Risk of Cardiovascular Disease in Elderly Patients: Results From the PROSPER Study. (2015) (33)
- Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial. (2020) (33)
- Total Ischaemic Burden European Trial (TIBET) Effects of ischaemia and treatment with atenoiol, nifedipine SR and their combination on outcome in patients with chronic stable angina on behalf of the TIBET study group (2005) (33)
- Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up (2014) (32)
- Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy (2012) (32)
- KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly. (2011) (32)
- Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease. (2019) (32)
- Lipoprotein-associated phospholipase A(2), inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). (2010) (32)
- Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO (2010) (32)
- Meta-analysis of genome-wide association studies of HDL cholesterol response to statins (2016) (31)
- Genetic variation in galectin-3 gene associates with cognitive function at old age (2012) (31)
- Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trial (2016) (30)
- Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly. (2011) (30)
- Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial (2020) (30)
- Outcomes of Induction of Labour in Women with Previous Caesarean Delivery: A Retrospective Cohort Study Using a Population Database (2013) (30)
- Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure (2013) (29)
- Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry. (2014) (29)
- Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect. (1998) (29)
- Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk (2014) (29)
- Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes (2018) (29)
- Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations (2013) (28)
- The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction (2002) (28)
- Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT) (2013) (28)
- A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation (2014) (28)
- Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study☆☆☆ (2013) (27)
- Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval (2013) (27)
- Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure (2016) (27)
- Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease (2000) (27)
- Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery (2013) (27)
- C-Reactive Protein and Genetic Variants and Cognitive Decline in Old Age: The PROSPER Study (2011) (27)
- Model validity and risk of bias in randomised placebo-controlled trials of individualised homeopathic treatment. (2016) (26)
- Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials (2021) (26)
- Effect of cold spells and their modifiers on cardiovascular disease events: Evidence from two prospective studies (2016) (26)
- A parallel group randomised open blinded evaluation of Acceptance and Commitment Therapy for depression after psychosis: Pilot trial outcomes (ADAPT) (2016) (26)
- The cardiovascular event reduction tool (CERT)--a simplified cardiac risk prediction model developed from the West of Scotland Coronary Prevention Study (WOSCOPS). (2000) (26)
- Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials (2016) (26)
- Genome-wide association meta-analysis of 30,000 samples identifies seven novel loci for quantitative ECG traits (2019) (26)
- Impact of nicorandil in angina: subgroup analyses (2004) (25)
- Profile of microvolt T‐wave alternans testing in 1003 patients hospitalized with heart failure (2012) (25)
- 25-Hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid. (2012) (25)
- Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9 (2018) (25)
- Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial Infarction (2018) (25)
- Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies (2015) (25)
- Total cerebral blood flow and mortality in old age (2013) (25)
- High Innate Production Capacity of Proinflammatory Cytokines Increases Risk for Death from Cancer: Results of the PROSPER Study (2009) (24)
- Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting (2019) (24)
- Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure (2013) (24)
- Impact of Chronic Kidney Disease on Use of Evidence-Based Therapy in Stable Coronary Artery Disease: A Prospective Analysis of 22,272 Patients (2014) (24)
- Socioeconomic Status and the Cerebellar Grey Matter Volume. Data from a Well-Characterised Population Sample (2013) (24)
- Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis (2019) (24)
- Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022) (23)
- Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population (2015) (23)
- Impact of Selection Bias on Estimation of Subsequent Event Risk (2017) (23)
- Long-term follow-up of lipid-lowering trials (2015) (22)
- Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles (2016) (22)
- Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension (2016) (22)
- Non‐adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT (2016) (22)
- Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events (2019) (21)
- Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) (2011) (21)
- Effect of Smoking on Blood Pressure and Resting Heart RateCLINICAL PERSPECTIVE (2015) (21)
- White Matter Lesion Progression: Genome-Wide Search for Genetic Influences (2015) (21)
- Early life socioeconomic status, chronic physiological stress and hippocampal N-acetyl aspartate concentrations (2012) (21)
- Blood Pressure Lowering Medication, Visit-to-Visit Blood Pressure Variability, and Cognitive Function in Old Age. (2015) (20)
- Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment (2018) (20)
- Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I f Inhibitor Ivabradine Trial (SHIFT) Trial (2016) (20)
- Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry (2018) (20)
- Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction. (2015) (20)
- Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris (2015) (20)
- Non-Homologous End-Joining Pathway Associated with Occurrence of Myocardial Infarction: Gene Set Analysis of Genome-Wide Association Study Data (2013) (20)
- Effect of Gender on Outcomes After Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex: A Subgroup Analysis of the EchoCRT Trial (2016) (20)
- Economic evaluation of the impact of nicorandil in angina (IONA) trial (2006) (20)
- High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk (2016) (19)
- Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases (2017) (19)
- Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium (2015) (19)
- Genetic variants in the KIF6 region and coronary event reduction from statin therapy (2010) (19)
- Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study. (2005) (19)
- Redefining Adverse and Reverse Left Ventricular Remodeling by Cardiovascular Magnetic Resonance Following ST-Segment–Elevation Myocardial Infarction and Their Implications on Long-Term Prognosis (2020) (18)
- The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment (2017) (18)
- Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventric (2006) (18)
- Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. (2002) (18)
- Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study. (2000) (17)
- Importance of sustained and “tight” blood pressure control in patients with high cardiovascular risk (2016) (17)
- Relationship between outdoor temperature and cardiovascular disease risk factors in older people (2016) (17)
- Living alone and cardiovascular disease outcomes (2019) (17)
- Effect of informed consent on patient characteristics in a stroke thrombolysis trial (2017) (17)
- A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of Actamax™ Adhesion Barrier (2016) (16)
- Effect of vitamin D supplementation on orthostatic hypotension: data from the Vitamin D in Isolated Systolic Hypertension randomized controlled trial (2014) (16)
- Secretory Phospholipase A2-IIA and Cardiovascular Disease A Mendelian Randomization Study (2017) (16)
- Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. (2015) (16)
- Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease (2020) (16)
- Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry (2015) (15)
- Chronotherapy in hypertension: the devil is in the details. (2020) (15)
- Family history of premature death from ischaemic heart disease is associated with an increased risk of delivering a low birth weight baby (2003) (15)
- Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium (2017) (15)
- Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity–Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy (2016) (15)
- Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly (2009) (15)
- Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes. (2018) (14)
- Subsequent Event Risk in Individuals With Established Coronary Heart Disease (2019) (14)
- Gene-gene Interaction Analyses for Atrial Fibrillation (2016) (14)
- N‐terminal pro–brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk (2014) (14)
- Associations of Cytomegalovirus Infection With All-Cause and Cardiovascular Mortality in Multiple Observational Cohort Studies of Older Adults (2020) (14)
- Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension (2015) (14)
- Spectral microvolt T‐wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure (2013) (14)
- ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment. (2014) (14)
- Visit-to-visit lipid variability: Clinical significance, effects of lipid-lowering treatment, and (pharmaco) genetics. (2018) (13)
- Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort. (1999) (13)
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995. (2004) (13)
- Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time (2020) (13)
- Using Electronic Health Records to Support Clinical Trials: A Report on Stakeholder Engagement for EHR4CR (2015) (13)
- Thromboxane Prostaglandin Receptor Antagonist and Carotid Atherosclerosis Progression in Patients With Cerebrovascular Disease of Ischemic Origin: A Randomized Controlled Trial (2014) (12)
- Ninety-nine independent genetic loci influencing general cognitive function include genes associated with brain health and structure (N = 280,360) (2017) (12)
- Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome (2019) (12)
- Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke (2016) (12)
- Nicorandil, Gastrointestinal Adverse Drug Reactions and Ulcerations: A Systematic Review (2016) (12)
- University of Dundee Stratification by Smoking Status Reveals an Association of CHRNA 5-A 3-B 4 Genotype with Body Mass Index in Never Smokers (2014) (12)
- Fractional flow reserve versus angiography in guiding management to optimize outcomes in non–ST-elevation myocardial infarction (FAMOUS-NSTEMI): Rationale and design of a randomized controlled clinical trial☆ (2013) (12)
- Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease. (2020) (11)
- Randomized Trial—PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving Hemodialysis (2021) (11)
- The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good (2014) (11)
- Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study (2018) (11)
- There is still a place for significance testing in clinical trials (2019) (11)
- Incidence of Pressure Sores in Geriatric Long-term Hospital Care (1995) (11)
- Natural variability of transient myocardial ischaemia during daily life: an obstacle when assessing efficacy of anti-ischaemic agents? (1996) (11)
- A randomized, double‐blind, placebo‐controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics (2019) (11)
- [Coronary artery disease in Russia: todays reality evidenced by the international CLARIFY registry]. (2013) (11)
- Systematic review and meta-analysis of randomised, placebo-controlled, trials of individualised homeopathic treatment (2015) (11)
- Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients (2015) (11)
- Incident heart failure in outpatients with chronic coronary syndrome: results from the international prospective CLARIFY registry (2020) (10)
- Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial (2015) (10)
- Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. (2002) (10)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (10)
- Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design (2015) (10)
- Clinical characteristics of unknown symptom onset stroke patients with and without diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch (2018) (10)
- Metabolic syndrome and diabetes mellitus. (2004) (10)
- Persistence of infarct zone T2 hyperintensity at 6 months after acute ST-elevation myocardial infarction: incidence, pathophysiology and prognostic implications (2017) (10)
- L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms (2020) (10)
- Genome wide association study of apparent treatment resistant hypertension in the CHARGE consortium: The CHARGE Pharmacogenetics Working Group. (2019) (10)
- Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II. (1991) (9)
- No Evidence for Genome-Wide Interactions on Plasma Fibrinogen by Smoking, Alcohol Consumption and Body Mass Index: Results from Meta-Analyses of 80,607 Subjects (2014) (9)
- Spatial QRS-T Angle and Cognitive Decline in Older Subjects. (2019) (9)
- International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina (2021) (9)
- Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study (2008) (9)
- Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses (2020) (9)
- The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trial (2020) (8)
- Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction (2017) (8)
- Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry (2019) (8)
- Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over (2018) (8)
- Improving Blood Pressure Control in Patients with Diabetes Mellitus and High Cardiovascular Risk (2011) (8)
- In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study. (2014) (8)
- Current Smoking Does Not Modify the Treatment Effect of Intravenous Thrombolysis in Acute Ischemic Stroke Patients—A Post-hoc Analysis of the WAKE-UP Trial (2019) (8)
- Is blood donation good for the donor? (1997) (8)
- Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension (2015) (8)
- A cardiovascular disease policy model: part 2—preparing for economic evaluation and to assess health inequalities (2016) (8)
- Penumbra and re-canalization acute computed tomography in ischemic stroke evaluation: PRACTISE study protocol (2017) (7)
- Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m. (2019) (7)
- Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT. (2019) (7)
- Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials (2019) (7)
- Author Correction: Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function (2019) (7)
- Pharmacogenomics Study of Thiazide Diuretics and QT Interval in Multi-Ethnic Populations: The Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) (2017) (7)
- Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease. (2020) (7)
- Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization Approach. (2009) (7)
- Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCT. (2021) (7)
- ESSENTIAL – The Studies of Oral Enoximone Therapy in Advanced Heart Failure (2005) (7)
- Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland. (2020) (7)
- Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. (2015) (6)
- Fine mapping the CETP region reveals a common intronic insertion associated to HDL-C (2015) (6)
- The metabolic syndrome is an independent predictor of cardiac events in WOSCOPS males (2003) (6)
- Global left ventricular systolic dysfunction in North Glasgow (1996) (6)
- Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction (2019) (6)
- Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS) (2016) (6)
- Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials (2018) (5)
- Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. (2021) (5)
- Genome-wide association study provides new insights into the genetic architecture and pathogenesis of heart failure (2019) (5)
- The influence of immediate physiotherapy in the out-patient management of acute knee injuries: a controlled study. (1990) (5)
- Sunday, 26 August 2012 (2012) (5)
- Two-year results of the randomised Diabetes Remission Clinical Trial (DiRECT) (2019) (5)
- Insulin resistance is a risk factor for diabetes but not cardiovascular disease in the elderly: results from long-term follow-up of the Prospective Study of Pravastatin in the Elderly at Risk trial (2014) (5)
- Validation of the myocardial-ischaemic-injury-index machine learning algorithm to guide the diagnosis of myocardial infarction in a heterogenous population: a prespecified exploratory analysis (2022) (5)
- Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial (2020) (5)
- b -blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study (2018) (5)
- 1.P.139 The cost-effectiveness of preventing initial coronary events with pravastatin: Results of the West of Scotland coronary prevention study economic analysis (1997) (5)
- Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease. (2021) (5)
- Ivabradine in stable coronary artery disease. (2014) (5)
- Quality of life with ivabradine in patients with angina pectoris: The SIGNIFY Quality of Life substudy (2015) (5)
- Lipid-Modifying Therapies and Risk of Pancreatitis (2012) (5)
- Coronary Thermodilution Waveforms After Acute Reperfused ST‐Segment–Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognosis (2018) (5)
- Long term follow up of the early repolarization pattern in participants in the West of Scotland Coronary Prevention study (2015) (5)
- Does the aldosterone: renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study (2007) (5)
- Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT (2017) (5)
- Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis (2023) (4)
- Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. Data from the international CLARIFY registry (2013) (4)
- Cognitive Function in Dementia-Free Subjects and Survival in The Old Age: The PROSPER Study. (2019) (4)
- Stroke in Hemodialysis Patients Randomized to Different Intravenous Iron Strategies: A Prespecified Analysis from the PIVOTAL Trial (2021) (4)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (4)
- Simple risk models to predict cardiovascular death in patients with stable coronary artery disease (2020) (4)
- Metformin and carotid intima‐media thickness in never‐smokers with type 1 diabetes: The REMOVAL trial (2020) (4)
- Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron Therapy. (2021) (4)
- Statin prescribing: is the reality meeting the expectations of primary care? (2005) (4)
- SurgiCal Obesity Treatment Study (SCOTS): protocol for a national prospective cohort study of patients undergoing bariatric surgery in Scotland (2015) (4)
- Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptide (2016) (4)
- Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial (2021) (4)
- Treatment in the Morning versus Evening (TIME) Study: Feasibility of an OnlineStudy (2016) (3)
- Corrigendum to “Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study” [Neuroimage Clin. 2 (2013) 646–57] (2015) (3)
- Polypharmacy, functional outcome and treatment effect of intravenous alteplase for acute ischaemic stroke (2020) (3)
- Angina clinical trial methodology. (1991) (3)
- Using Centrally Held Data to Validate Carotid Surgery Outcome Data (2013) (3)
- Management strategies and 5-year outcomes in Polish patients with stable coronary artery disease in the CLARIFY registry versus other European countries (2019) (3)
- Monday, 27 August 2012 (2012) (3)
- Observer Agreement on Computed Tomography Perfusion Imaging in Acute Ischemic Stroke (2019) (3)
- Does the exercise protocol matter when assessing the anti-anginal effects of drug therapy? (1995) (3)
- Effect of ivabradine on early readmissions after hospitalization for worsening heart failure. (2015) (3)
- Clinical Characteristics and Outcome of Patients with Lacunar Infarcts and Concurrent Embolic Ischemic Lesions (2019) (3)
- Abstract TMP24: Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2) (2018) (3)
- One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention: The T-TIME Randomized Trial. (2020) (3)
- Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus noncardiologists. Results from the international prospective CLARIFY registry. (2017) (3)
- Financial impact of ivabradine on reducing heart failure penalties under the Hospital Readmission Reduction Program (2017) (3)
- OMAPATRILAT IN PERSONS WITH ENHANCED RISK OF ATHEROSCLEROTIC EVENTS: THE OPERA TRIAL (2000) (3)
- The genomics of heart failure: design and rationale of the HERMES consortium (2021) (3)
- BETA BLOCKER DOSAGE AND USE OVER TIME IN THE SYSTOLIC HEART FAILURE TREATMENT WITH THE IF INHIBITOR IVABRADINE TRIAL (SHIFT) STUDY (2015) (2)
- Abstract 16738: Estimation of Decrements of Utility Associated With Hospitalizations in a Population With Heart Failure From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) (2016) (2)
- Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States. (2016) (2)
- Metformin in type 1 diabetes: methods and baseline characteristics of the REMOVAL trial (2016) (2)
- Abstract 814: CRP and Risk of Vascular Events in PROSPER (2006) (2)
- Effect of carvedilol in patients with or without renal impairment after myocardial infarction: analysis of the carvedilol post-infarct survival control in left ventricular dysfunction (CAPRICORN) study. (2010) (2)
- ‘N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS’ [Eur Heart J (2013); 34(6):443–450] (2013) (2)
- Specificities of Ischemic Stroke Risk Factors in Arab-Speaking Countries (2017) (2)
- Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by quantitative T2-weighted cardiac magnetic resonance (2015) (2)
- Endovascular therapy for acute ischaemic stroke (2016) (2)
- The WASH study (warfarin/aspirin study in heart failure) rationale, design and end-points (1999) (2)
- Management strategies and 5-year outcomes in Polish patients with stable coronary artery disease versus other European countries: data from the CLARIFY registry. (2019) (2)
- 246Effect of Ivabradine on Mortality in Patients with heart failure and a reduced left ventricular ejection fraction not receiving a beta-blocker: an analysis from SHIFT (2017) (2)
- Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes (From the CLARIFY Registry). (2021) (2)
- Abstract 3363: Anti-Ischemic and Antianginal Efficacy of Ivabradine, a Selective and Specific If Current Inhibitor, in Elderly Patients with Stable Angina (2006) (2)
- Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation (2017) (2)
- Abstract 4024: 15 Year Follow-Up of the West of Scotland Coronary Prevention Study (2006) (2)
- Post-hoc Analysis of Outcome of Intravenous Thrombolysis in Infarcts of Infratentorial Localization in the WAKE-UP Trial (2019) (2)
- Rationale and design of a randomised trial of intravenous iron in patients with heart failure (2022) (2)
- Modelling total coronary heart disease burden and long-term benefit of cholesterol lowering in middle aged men with and without a history of cardiovascular disease (2017) (2)
- A parallel group randomised open blinded evaluation of Acceptance and Commitment Therapy for Depression After Psychosis: A Pilot Trial Protocol (ADAPT) (2016) (2)
- HYPERTENSION, MICROVASCULAR PATHOLOGY AND PROGNOSIS IN PATIENTS WITH AN ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (2017) (2)
- Sustained effect of caftopril on the attenuation of infarct expansion following acute myocardial infarction (1991) (2)
- The REMOVAL trial: metformin reduces progression of mean carotid intima-media thickness (cIMT) in never smokers with type 1 diabetes (2018) (2)
- Intravenous Iron in Patients Undergoing Maintenance Hemodialysis [vol 380 (5), p502, 31 Jan 2019] (2019) (2)
- Publisher Correction: Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability (2021) (1)
- Statins and blood pressure. (2008) (1)
- Effects of Heart Rate Reduction in Black Patients from the SHIFT (Systolic Heart Failure treatment with the If Inhibitor Ivabradine Trial) Study (2015) (1)
- Clinical trials in silent ischaemia: lessons from TIBET. (1993) (1)
- High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis (2021) (1)
- Prognostic importance of pretreatment and on-treatment blood pressure: Further analysis of the ACTION database and the effect of nifedipine gastrointestinal therapeutic system (2016) (1)
- Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage (2014) (1)
- Clinical profile, outcomes, and ivabradine effects in patients with chronic obstructive pulmonary disease and chronic heart failure: The SHIFT trial analysis (2013) (1)
- Pathophysiology of myocardial remodeling in survivors of ST-elevation myocardial infarction revealed by native T1 mapping: inflammation, remote myocardium and prognostic significance (2015) (1)
- The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure (2013) (1)
- The REMOVAL trial (Reducing with Metformin Vascular Adverse Lesions) in Type 1 diabetes: methods and baseline characteristics (2016) (1)
- 1.P.153 Influence of pravatatin and plasma lipids on clinical events, in the West of Scotland Coronary Prevention Study (WOSCOPS) (1997) (1)
- Coronary disease prevention: A study (1996) (1)
- Effect of Comorbidities and Risk Factors on Outcomes and Ivabradine’s Effects in Patients With Chronic Systolic Heart Failure in the SHIFT Trial (2015) (1)
- Predictors of glucose intolerance (GI) in the West of Scotland Coronary Prevention Study (WOSCOPS) (2000) (1)
- N-T Pro-BNP is a powerful predictor of outcome in patients with stable angina: A substudy of the IONA trial (2003) (1)
- Bene fi cial effects of ivabradine in patients with heart failure , low ejection fraction , and heart rate above 77 (2019) (1)
- Abstract 18395: Safety of Continuing Ivabradine Treatment During Hospitalization for Worsening of Heart Failure in the SHIFT Study (2015) (1)
- Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry (2020) (1)
- Cardiac Safety of the Sino Atrial Node f Channel Blocker Ivabradine in Chronic Heart Failure: An ECG-Holter Sub-study (2014) (1)
- Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY Registry (2020) (1)
- Intravenous iron dosing and infection risk in hemodialysis patients: a pre-specified secondary analysis of the PIVOTAL trial (2020) (1)
- Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations (2021) (1)
- Do statins reduce the risk for diabetes by improving exercise capacity? Response (2001) (1)
- Time to treat as independent (2010) (1)
- An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial (2022) (1)
- Erratum to “Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency” [Eur J Heart Fail 2016;18:482‐489] (2016) (1)
- Variation in the IL-10 gene is a marker for risk prediction of cognitive function (2010) (1)
- An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial (2022) (1)
- Using Electronic Health Records to Support Clinical Trials : A Report on Stakeholder Engagement for EHR 4 CR (2015) (1)
- Large scale trans-ethnic meta-analyses identify novel rare and common variants associated with blood pressure and hypertension (2016) (1)
- Genome-Wide Meta-analysis of Variant-by-Diuretic Interactions as Modulators of Lipid Traits in Persons of European and African Ancestry (2019) (1)
- Commentary on Vickers (2014) (1)
- Effect of vitamin D supplementation on orthostatic hypotension–data from the VitDISH trial (2013) (1)
- Efficacy and Safety of Ivabradine in Patients with Chronic Systolic Heart Failure and Low Blood Pressure in the SHIFT Trial (2013) (1)
- Metabolic syndrome and diabetes mellitus - Response. (2004) (1)
- Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus non-cardiologists : the international prospective CLARIFY registry (2017) (1)
- Genetic Loci In fl uencing Myocardial Mass (2016) (1)
- Our inability to predict thromboembolic events after prosthetic valve surgery. (2006) (1)
- MO016MYOCARDIAL INFARCTION IN THE PIVOTAL STUDY OF IV IRON IN HAEMODIALYSIS: A PRE-SPECIFIED SECONDARY ANALYSIS (2020) (1)
- The ABCA1 gene variant and heart disease risk reduction in the elderly during pravastatin treatment (2013) (1)
- Other medical conditions (2013) (1)
- The kidney, subclinical thyroid disease and cardiovascular outcomes in older patients (2019) (1)
- SurgiCal Obesity Treatment Study (SCOTS): a prospective, observational cohort study on health and socioeconomic burden in treatment-seeking individuals with severe obesity in Scotland, UK (2021) (1)
- Clinical profiles and outcomes of patients with chronic heart failure and chronic obstructive pulmonary disease: efficacy and safety of Ivabradine. a SHIFT study analysis (2013) (1)
- Cracking the NNT Code: Effect of Ivabradine on Recurrent Hospitalizations (2015) (1)
- Ivabradine and outcomes in chronic heart failure – Authors' reply (2010) (1)
- Randomized comparison of chest pain evaluation with FFRCT or standard care: Factors determining US costs. (2022) (1)
- Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium (2022) (1)
- 13 Natural history and clinical significance of infarct zone extracellular volume and remodelling in survivors of acute STEMI (2015) (1)
- Tuesday, 28 August 2012 (2012) (1)
- New-onset atrial fibrillation in chronic coronary syndrome outpatients: Insights from the international CLARIFY registry (2022) (1)
- P3625Barriers to the use and titration of betablockers in patients with stable coronary artery disease. Insights from the CLARIFY registry (2018) (1)
- P5010Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry (2019) (1)
- Prognosis in patients with prior myocardial infarction and PEGASUS-TIMI 54 criteria in the CLARIFY registry (2020) (1)
- 2362Impact of diabetes on 5-year clinical outcomes in stable coronary artery disease, across multiple geographical regions and ethnicities. Insights from the CLARIFY registry (2018) (1)
- 3294Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY registry (2019) (1)
- CCS patients with polyvascular disease are a high risk but heterogenous subset of patients: insights from the CLARIFY registry (2020) (0)
- PROGNOSTIC SIGNIFICANCE OF QUANTITATIVE MEASURES OF MYOCARDIAL INFARCT PATHOLOGY IN SURVIVORS OF ST-ELEVATION MYOCARDIAL INFARCTION (2015) (0)
- No genetic determinants of differential cardiovascular event reduction by pravastatin in the PROSPER/PHASE study (2013) (0)
- The prognostic value for stroke of a nurse-led screening assessment of 71,527 Scottish middle-aged men (2001) (0)
- Contribution of perindopril in the treatment of congestive heart failure (1995) (0)
- Myocardial Salvage After Reperfusion Therapy in Patients With Acute Myocardial Infarction (2003) (0)
- Chronic coronary syndrome patients with polyarterial disease are a high risk but heterogenous subset of patients. Insights from the CLARIFY registry (2021) (0)
- 684 Gastrointestinal Events and Adverse Reactions on Selective and Non Selective Cyclooxygenase Inhibitors in the Large Randomised Controlled SCOT Trial (2016) (0)
- Burden of Disease/ Epidemiology of Illness (2014) (0)
- High-Sensitivity Cardiac Troponin Concentration and Risk of First-EverCardiovascular Outcomes in154,052 Participants (0)
- P33 Associations of outdoor temperature and cardiovascular disease risk factors in the elderly: evidence from two Northern European prospective studies (2016) (0)
- Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction. (2023) (0)
- High-sensitivity cardiac troponin, statin threapy and risk of cardiovascular disease (2015) (0)
- TCT-189 Effect of Low-Dose Intracoronary Alteplase on Global Circumferential Strain: Myocardial Strain Cardiovascular Magnetic Resonance Substudy of the T-TIME Trial (2021) (0)
- Intravenous iron Intravenous Iron in Patients Undergoing Maintenance Hemodialysis (2019) (0)
- P1371HEART FAILURE HOSPITALISATIONS IN THE PIVOTAL TRIAL OF IV IRON IN HAEMODIALYSIS PATIENTS: A PRE-SPECIFIED SECONDARY ANALYSIS (2020) (0)
- Relationship between C-Reactive Protein and the Electrocardiograph in Unselected Admissions with Acute Chest Pain (1998) (0)
- Edinburgh Research Explorer Outcomes of induction of labour in women with previous caesarean delivery (2018) (0)
- NON-INVASIVE VERSUS INVASIVE MANAGEMENT IN PATIENTS WITH PRIOR CORONARY ARTERY BYPASS SURGERY WITH A NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME: COMPARISONS BETWEEN THE RANDOMIZED CONTROLLED PILOT TRIAL AND REGISTRY (2018) (0)
- THE INTRACRANIAL-B2LEED3S SCORE AND THE RISK OF INTRACRANIAL HEMORRHAGE IN ISCHAEMIC STROKE PATIENTS UNDER ANTIPLATELET TREATMENT (low Body mass index, Blood pressure, Lacune, Elderly, asian Ethnicity, cardiovascular Disease, cerebrovascular Disease, Dual antithrombotic treatment or anticoagulant, S (2016) (0)
- Edinburgh Research Explorer Secretory Phospholipase A2-IIA and Cardiovascular Disease (2018) (0)
- 2 Coronary flow reserve and index of microvascular resistance in acute stemi (2016) (0)
- Subclinical thyroid dysfunction, functional capacity and cognitive performance in old age (2013) (0)
- The association between LDL-C and outcome: The pravastatin pooling project (2000) (0)
- Relationship between achieved levels of LDL cholesterol and outcome in the west of Scotland coronary prevention study (WOSCOPS) (1999) (0)
- Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by non-contrast T1 mapping cardiac magnetic resonance (2015) (0)
- Abstract 18347: Prognostic Significance of Activation Delay by Cross Correlation Analysis Using Tissue Doppler Imaging in Patients With Heart Failure and Narrow QRS Duration; an Echocardiography Guided Cardiac Resynchronization Therapy (Echo-CRT) Trial Substudy of Patients Not Randomized to CRT (2017) (0)
- Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies : The CHARGE Consortium Dehghan (2016) (0)
- Does the aldosterone: renin ratio (ARR) predict the efficacy of spironolactone over bendroflumethiazide in hypertension? The RENALDO study (2008) (0)
- 1.P.145 A follow-up report on mortality in the West of Scotland Coronary Prevention Study (WOSCOPS) (1997) (0)
- P4591Outcomes of stable coronary artery disease worldwide. Insights from the CLARIFY registry (2018) (0)
- between outdoor temperature and disease risk factors in older people. (2016) (0)
- Intravenous Iron and Maintenance Hemodialysis. Reply. (2019) (0)
- Original Contribution Apolipoprotein E Genotype, Plasma Cholesterol, and Cancer: A Mendelian Randomization Study (2009) (0)
- For peer review only Methodology of a large streamlined safety study: protocol of the Standard care versus Celecoxib Outcome Trial (SCOT trial) (2012) (0)
- Clinical outcomes for patients with stable coronary disease in Australia - findings from the CLARIFY registry (2015) (0)
- University of Dundee Prevention And Treatment of Hypertension With Algorithm-based therapy ( PATHWAY ) number 2 (2015) (0)
- Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States. (2016) (0)
- Surveys of triallists’ current practice (2014) (0)
- Chapter 9 ApoE genotype , plasma cholesterol , and cancer : A Mendelian randomization study (2010) (0)
- The effect of spironolactone on pulse wave characteristics in hypertension: influence of the aldosterone to renin ratio (ARR) (2007) (0)
- Gerneralizability of the REDUCE-IT trial in patients with stable coronary artery disease. An analysis from the CLARIFY registry (2019) (0)
- Contents Vol. 131, 2015 (2015) (0)
- Low cost database management in clinical trials—Riding the tidal wave of technology (1991) (0)
- CURRENT SMOKING, MICROVASCULAR PATHOLOGY AND ADVERSE OUTCOME AFTER ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: NEW PATHOPHYSIOLOGICAL INSIGHTS (2017) (0)
- Female gender does not impact outcomes in patients with postinfarct left ventricular dysfunction treated with carvedilol (2002) (0)
- C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Epidemiology (2007) (0)
- 1343 HIGH DOSE ATORVASTATIN ASSOCIATED WITH INCREASED RISK OF SIGNIFICANT HEPATOTOXICITY IN COMPARISON TO SIMVASTATIN: A RETROSPECTIVE COHORT STUDY USING THE UK GENERAL PRACTICE RESEARCH DATABASE (2012) (0)
- TCT-82 Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS - NSTEMI) Clinical Trial: Relationships Between FFR and Angiographic Stenosis Severity at Baseline. (2013) (0)
- Abstract: 535 CHOLESTEROL ABSORPTION AND SYNTHESIS MARKERS IN INDIVIDUALS WITH AND WITHOUT A CHD EVENT DURING PRAVASTATIN THERAPY: INSIGHTS FROM THE PROSPER TRIAL (2009) (0)
- 1 Subsequent Event Risk in Individuals with Established Coronary Heart Disease : Design and Rationale of the GENIUS-CHD Consortium Running title : (2019) (0)
- BLOOD PRESSURE CONTROL & CARDIOVASCULAR OUTCOME IN CORONARY ARTERY DISEASE: EVIDENCE FROM THE ACTION TRIAL: 6C.06 (2011) (0)
- An ABC of information management in primary prevention trials (1992) (0)
- A COMPREHENSIVE COMPARISON OF THE PATHOPHYSIOLOGICAL AND PROGNOSTIC SIGNIFICANCE OF CORONARY FLOW RESERVE AND THE INDEX OF MICROVASCULAR RESISTANCE IN THE CULPRIT CORONARY ARTERY OF PATIENTS WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION (2016) (0)
- 456-P: The REMOVAL Trial: Effect of Metformin on Markers of Cardiometabolic Risk in Patients with Type 1 Diabetes (2019) (0)
- Prognostic significance of quantitative measures of myocardial infarct pathology using native T1 mapping, in survivors of ST-elevation myocardial infarction (2015) (0)
- PROGNOSTIC VALUE OF BLOOD PRESSURE IN PATIENTS WITH CORONARY ARTERY DISEASE: EVIDENCE FROM THE ACTION TRIAL DATABASE: 9A.05 (2010) (0)
- Randomised trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib (2016) (0)
- Y Chromosome Haplogroup as a Predictor of Coronary Artery Disease in Men (2010) (0)
- Clinical Presentation and Management of Outpatients with Stable Coronary Artery Disease—Australian Baseline Characteristics of the CLARIFY Registry (2012) (0)
- Systematic review of methods for specifying a target difference (2014) (0)
- Abstract P103: Genome-Wide Study of Gene Variants Associated with Differential Event Reduction by Pravastatin Therapy (2011) (0)
- The Role of Iron in Calciphylaxis—A Current Review (2022) (0)
- The BEAUTIFUL study: Baseline characteristics of included patients (2007) (0)
- Geographic variations in prevalence and management of cardiovascular risk factors in 33 283 outpatients with CAD: data from the contemporary CLARIFY registry from 45 countries (2013) (0)
- Repeated Heart Rate Measurement and Cardiovascular Outcomes in LVSD (2015) (0)
- 044 A RANDOMISED CONTROLLED TRIAL OF DEFERRED STENTING VERSUS IMMEDIATE STENTING TO PREVENT NO-REFLOW IN ACUTE ST-ELEVATION MYOCARDIAL INFARCTION (2013) (0)
- Bivard, A. et al. (2017) Impact of computed tomography perfusion imaging on the response to tenecteplase in ischemic stroke: analysis of two (2016) (0)
- MO015HAEMODIALYSIS VASCULAR ACCESS THROMBOSIS: AN ANALYSIS OF EVENTS FROM THE PROACTIVE IV IRON THERAPY IN HAEMODIALYSIS PATIENTS (PIVOTAL) TRIAL (2020) (0)
- Lymphotoxin-alpha polymorphism is a risk factor for stroke. The PROSPER study (2010) (0)
- Visit-to-visit blood pressure variability, average blood pressure and cognitive function in old age (2013) (0)
- 80 Two Year Prognosis in Stable Coronary Artery Disease: A Prospective Study of 2346 Patients in UK Primary Care (2016) (0)
- identifies 148 independent genetic loci influencing general cognitive function Permalink (2018) (0)
- University of Groningen A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function Porcu, (2013) (0)
- Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes. (2023) (0)
- The changing course of aortic valve disease in Scotland: hospitalizations, outcomes and temporal trends (2011) (0)
- Associations of outdoor temperature and cardiovascular disease risk factors in the elderly: evidence from two Northern European prospective studies (2016) (0)
- 115 Persistence of Infarct Zone Oedema at 6 Months after Acute ST-elevation Myocardial Infarction: Incidence, Pathophysiology and Association with Left Ventricular Remodelling (2016) (0)
- Feasibility/eligibility of T‐wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply (2012) (0)
- Low-dose intracoronary alteplase during primary percutaneous coronary intervention in patients with acute myocardial infarction: the T-TIME three-arm RCT (2020) (0)
- Evidence for a Threshold Effect Impact of Apo(a) Length Polymorphism and the Control of Plasma Lp(a) Concentrations (2013) (0)
- Proportion of patients with previously uncontrolled hypertension who achieve target blood pressure through participation in the BHS's prevention and treatment of hypertension with algorithm based therapy (PATHWAY) trials (2012) (0)
- Use of risk scores to identify lower and higher risk subsets among COMPASS‐eligible patients with chronic coronary syndromes. Insights from the CLARIFY registry (2020) (0)
- 35P Record linkage — An aid to adverse event reporting in clinical trials (1994) (0)
- PROGNOSTIC SIGNIFICANCE OF CO-EXISTING PERSISTENT EDEMA AND HEMORRHAGE AT 6 MONTHS IN SURVIVORS OF ST-ELEVATION MYOCARDIAL INFARCTION (2017) (0)
- 12 The influence of microvascular obstruction on the relationship between remote zone extracellular volume and subsequent left ventricular volumes in survivors of ST-elevation myocardial infarction (2015) (0)
- Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprolol. (1994) (0)
- Department of Error (2021) (0)
- Guidelines for investigation of associations between insulin and cancer risk using prescription databases. (2010) (0)
- Myocardial haemorrhage after acute reperfused ST-elevation myocardial infarction evolves progressively and contributes to the early bimodal pattern in T2-relaxation time: advanced imaging and clinical significance (2016) (0)
- 9 Routine non-invasive vs invasive management in patients with prior CABG with a NSTE-ACS: a randomised controlled trial (2018) (0)
- Investigation of the endocrine and haemodynamic changes in resistant hypertension, and its response to spironolactone or amiloride: the PATHWAY-2 mechanisms study (2018) (0)
- Author's response to reviews Title: Study of therapeutic hypothermia (32-35degreesC) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial). Outcome of the Pilot phase of the trial Authors: (2013) (0)
- Abstract 16931: The Changing Course of Aortic Valve Disease in Scotland: Hospitalizations, Outcomes and Temporal Trends (2011) (0)
- Genome-wide association meta-analysis of 30,000 samples identifies seven novel for quantitative traits. (2018) (0)
- Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al. (2017) (0)
- Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomes (2023) (0)
- Essential considerations in the investigation of associations between insulin and cancer risk using prescription databases (2009) (0)
- PATHOPHYSIOLOGY OF MYOCARDIAL REMODELING IN SURVIVORS OF ST-ELEVATION MYOCARDIAL INFARCTION: INFLAMMATION, REMOTE MYOCARDIUM AND PROGNOSIS (2015) (0)
- Pravastatin and coronary heart disease [3] (multiple letters) (1998) (0)
- Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation (0)
- Observer reliability of CT Perfusion scans (2016) (0)
- 017 Microvolt T-wave Alternans (MTWA) testing in “real world” heart failure (HF): a study of prevalence and incremental prognostic value (2012) (0)
- POTENTIAL IMPACT OF THE 2017 ACC/AHA HIGH BLOOD PRESSURE GUIDELINE IN NORMOTENSIVE PATIENTS WITH STABLE CORONARY ARTERY DISEASE: INSIGHTS FROM THE CLARIFY REGISTRY (2018) (0)
- Thyroid hormone replacement therapy for subclinical hypothyroidism in adults: systematic review and meta-analysis of randomized-controlled trials (2018) (0)
- University of Dundee Pathophysiology of LV Remodeling in Survivors of STEMI Inflammation, Remote Myocardium, and Prognosis Carrick, (2016) (0)
- 129 Myocardial salvage during primary PCI can be predicted in the Cath lab (2011) (0)
- Primary prevention trials of cholesterol lowering agents: A tale of three trials (1991) (0)
- Authors' Reply. (2020) (0)
- INCIDENCE AND PROGNOSTIC IMPLICATIONS OF THE PRESENCE OF MULTIPLE COMPLEX PLAQUES IN SURVIVORS OF ST-ELEVATION MYOCARDIAL INFARCTION (2017) (0)
- The Reply. (2018) (0)
- Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking. (2020) (0)
- S-28-1: CARDIOVASCULAR OUTCOMES IN ADULTS WITH HYPERTENSION WITH EVENING VERSUS MORNING DOSING OF USUAL ANTIHYPERTENSIVES IN THE UK. THE TIME STUDY (2023) (0)
- Effect of carvedilol on major cardiovascular events in post-infarction patients treated with angiotensin converting enzyme inhibitors: Further analysis of the capricorn trial (2003) (0)
- Vitamin K supplementation to improve vascular stiffness in chronic kidney disease - the K4Kidneys randomised controlled trial (2020) (0)
- WITHDRAWN: The beautiful study: Baseline characteristics of included patients (2007) (0)
- Outcomes of induction of labor in women with previous caesarean section (2011) (0)
- Guidance on specifying the target difference in a randomised controlled trial sample size calculation (2014) (0)
- Sudden death referrals to the West of Scotland Inherited Cardiac Conditions Clinic: an overview of findings in probands with a structurally normal heart (2013) (0)
- Clinical Implications. (2018) (0)
- 5 Relationships between infarct zone extracellular volume and clinical measures of ischaemia and reperfusion in acute STEMI survivors (2015) (0)
- 114 Persistence of Haemoglobin Degradation Products within Infarct Scar Tissue after ST-elevation Myocardial Infarction: Incidence, Correlates and Implications for Left Ventricular Remodelling (2016) (0)
- Development and implementation of a recruitment strategy to better identify people ‘at risk’ for cardiovascular disease for human dietary intervention studies (2012) (0)
- University of Southern Denmark Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib (2017) (0)
- 63EVALUATION OF GDF-15 AS A CANDIDATE BIOMARKER FOR HEALTH AND VASCULAR FUNCTION IN OLDER PATIENTS WITH HYPERTENSION (2016) (0)
- Abstract 17546: Effect of Intravenous Ferric Carboxymaltose on Symptoms and Quality of Life in Iron-Deficient Patients With Chronic Heart Failure With and Without Anemia: A Sub-Analysis of the FAIR-HF Trial (2010) (0)
- Use of the West of Scotland Coronary Prevention Study bio-bank to provide new insights into the control of plasma lipoprotein(a) concentrations. (1999) (0)
- VARIATION AT THE LDLR GENE IS ASSOCIATED WITH PLASMA LIPID LEVELS AND CHD IN THE PROSPER STUDY (2008) (0)
- Abstract 2496: Eplerenone Attenuates Left Ventricular Remodeling after Acute Myocardial Infarction in Patients with Left Ventricular Systolic Dysfunction (2007) (0)
- Department of Error (2021) (0)
- P240Prognostic impact and major determinants of physical activity level in a real-life SCAD population: insights from the CLARIFY registry (2018) (0)
- Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years (2017) (0)
- 102EFFECT OF VITAMIN D SUPPLEMENTATION ON ORTHOSTATIC HYPOTENSION – DATA FROM THE VITDISH TRIAL (2014) (0)
- 2018 Peer Reviewers (2019) (0)
- 4054Betablockers and outcomes in stable coronary artery disease. Insights from the CLARIFY registry (2018) (0)
- ASSOCIATION OF BLOOD PRESSURE LOWERING MEDICATION WITH VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY AND COGNITIVE FUNCTION IN OLD AGE (2014) (0)
- Wednesday, 29 August 2012 (2012) (0)
- FP08-MO-01 Rationale, design and patients' baseline characteristics of the PERFORM study (2009) (0)
- Public access defibrillators - Defibrillators in public places save lives - Reply (2003) (0)
- More drugs and better blood pressure control lead to improved cardiovascular outcomes: evidence from the ACTION database (2013) (0)
- PTU-214 Nicorandil and gastrointestinal adverse drug reactions (adr): a systematic review (2015) (0)
- 2211Prevalence, incidence and prognostic implications of left bundle branch block in patients with stable coronary artery disease. an analysis from the CLARIFY registry (2019) (0)
- THE IMPACT OF CHRONIC KIDNEY DISEASE ON USE OF EVIDENCE BASED THERAPY IN STABLE CORONARY ARTERY DISEASE: A PROSPECTIVE ANALYSIS OF 22,560 PATIENTS (2013) (0)
- Ivabradine in heart failure: what about digoxin? – Authors' reply (2008) (0)
- The top ten factors related to morbidity and mortality in patients with chronic heart failure and LVSD: a SHIFT prognostic model (2013) (0)
- Subject Index Vol. 27, 2009 (2009) (0)
- Microvolt T‐wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply (2012) (0)
- risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: additive value of nt-probnp (2015) (0)
- Prediction of major coronary events in stable angina: The IONA study (2003) (0)
- 127 CHARACTERISTICS AND TREATMENT OF 2346 PATIENTS WITH STABLE CORONARY ARTERY DISEASE IN UK PRIMARY CARE (2013) (0)
- G-015 PROGNOSTIC VALUE OF BLOOD PRESSURE AND “EARLY” BLOOD PRESSURE CONTROL IN PATIENTS WITH CORONARY ARTERY DISEASE: EVIDENCE FROM THE “ACTION” DATABASE (2011) (0)
- Assessing therapies in rare disease patients: re-evaluating the n-of-one crossover design (2012) (0)
- Diabetes in the West of Scotland Coronary Prevention Study Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart (2003) (0)
- Genome-wide association and functional follow-up reveals new loci for kidney function | NOVA. The University of Newcastle's Digital Repository (2012) (0)
- Abstract 14102: Associations Between Thrombin Generation and the Risk of Cardiovascular and Cerebrovascular Events in the Elderly: Results From the PROSPER Study (2013) (0)
- Abstract 12413: Haemoglobin and Change in Haemoglobin Status Predict Mortality, Cardiovascular Events and Bleeding in Stable Coronary Artery Disease: A Clarify Registry Analysis of 21,829 Patients From 45 Countries (2015) (0)
- Prevalence, incidence and prognostic implications of left bundle branch block in patients with stable coronary artery disease. An analysis from the CLARIFY registry (2020) (0)
- 89-04: Gender Effects of CRT in Patients with QRS Duration <130 ms in EchoCRT (2016) (0)
- Contents Vol. 27, 2009 (2009) (0)
- Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2021) (0)
- 81: Outcomes of induction of labor in women with previous caesarean section (2011) (0)
- SaO033IV IRON DOSING AND INFECTION RISK IN THE PIVOTAL TRIAL: A PRE-SPECIFIED SECONDARY ANALYSIS (2019) (0)
- The effect of induction of labour on perinatal mortality and obstetric outcomes: a population database study (2010) (0)
- Population screening for randomization into large scale cholesterol reduction clinical trials (1992) (0)
- Induction of Labour in Scotland between 1981-2007: The Effect on Mode of Delivery (2010) (0)
- AB1029 Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease (ALL-HEART) study: baseline characteristics of the randomised patient population (2018) (0)
- A77 Modeling the association between compliance and response to treatment in primary prevention trials of cholesterol lowering drugs (1996) (0)
- Survey from sent to UK- and Ireland-based triallists (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ian Ford?
Ian Ford is affiliated with the following schools:
